Efficacy and safety of ipragliflozin as an add-on to a sulfonylurea in Japanese patients with inadequately controlled type 2 diabetes: results of the randomized, placebo-controlled, double-blind, phase III EMIT study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and safety of ipragliflozin as an add-on to a sulfonylurea in Japanese patients with inadequately controlled type 2 diabetes: results of the randomized, placebo-controlled, double-blind, phase III EMIT study

59

Citations

22

References

2014

Year

Atsunori Kashiwagi, Noriko Akiyama, Takanori Shiga, Kenichi Kazuta, Atsushi Utsuno, Satoshi Yoshida, Eiji Ueyama

Diabetology International

Metabolic SyndromeDiabetes ManagementDiabetesPharmacologyType 2PharmacotherapyDiabetes MellitusMedicineJapanese Patients

References

	Year	Citations

Page 1